Find information on thousands of medical conditions and prescription drugs.

Evista

Raloxifene is an oral selective estrogen receptor modulator which is used in the prevention of osteoporosis in postmenopausal women. There has been some evidence that raloxifene can reduce the incidence of breast cancer, but this has yet to be proven in a clinical setting. Raloxifene is produced by Eli Lilly Pharmaceuticals and is sold under the brand name Evista.

SERMs mimic estrogen in some tissues and have anti-estrogen activity in others. Other SERMs, such as Pfizer's lasofoxifene and Wyeth's bazedoxifene are in the late stages of clinical development.

Home

E-Base

Edecrin

Effexor

Elavil

Elidel

Eligard

Elitek

Elmiron

Elspar

Emtriva

Endep

Enulose

Epi-pen

Epinephrine

Epirubicin

Epitol

Epivir

Epogen

Eryc

Eryped

Esgic

Esmolol

Estrace

Estring

Estrone

Evista

Exelon

Exemestane

Hexal Australia

Read more at Wikipedia.org

• [List your site here Free!]

Eli Lilly warns pharmacists about Evista o -E-Vista confusion
From Drug Store News, 5/25/98 by Kendall Shaw

Eli Lilly and Co. has issued a warning to pharmacists regarding potential for errors in filling Evista prescriptions. Evista @ (raloxifene HCI) 60mg tablets, manufactured and sold by Eli Lilly and Co. and recently approved for the prevention of postmenopausal osteoporosis, is not the same as Vista (hydroxyzine HCI), formerly manufactured by Seatrace Pharmaceuticals. Generic hydroxyzine HCI should not be substituted for Evista; they are different products with different indications.

Return to Evista

Home

Contact

Resources

Exchange Links

ebay